Global inequities in the survival of extremely preterm infants: a systematic review and meta-analysis

Temesgen Getaneh1,2, Nusrat Homaira3,4,5, Habtamu Kasaye6,7

  • 1College of Health Science, Midwifery Department, Debre Markos University, Debre Markos University, Debre Markos, Ethiopia. temugetaneh@gmail.com.

BMC Pediatrics
|July 31, 2025
PubMed

Insights

Global survival for extremely preterm infants is 61.4%, but significantly lower in low-income countries. Improvements were noted, yet disparities persist, highlighting the need for tailored neonatal care strategies.

Area of Science:

  • Neonatal Medicine
  • Global Health
  • Perinatal Epidemiology

Background:

  • Neonatal care advances improve survival for extremely preterm infants.
  • Survival rate disparities complicate policy standardization.
  • Global variations necessitate understanding of regional outcomes.

Purpose of the Study:

  • Determine global survival rates of extremely preterm infants.
  • Compare survival rates across income levels.
  • Analyze survival trends over the past two decades.

Main Methods:

  • Systematic search of major databases (PubMed, EMBASE, etc.).
  • Included peer-reviewed studies on infants born before 29 weeks gestation (2000-2024).
  • Compared outcomes between two epochs: 2000-2015 and 2016-2024.

Main Results:

  • 61.4% of extremely preterm infants survived to discharge.
  • Survival was significantly lower in low- and middle-income countries (44.3%) vs. high-income countries (69.3%).
  • Low- and middle-income countries showed improvement from 38% to 44.8% survival between epochs.

Conclusions:

  • Extremely preterm infant survival varies widely, with <50% survival in low- and middle-income countries.
  • Improvements noted in low- and middle-income countries during the SDG period, but data limitations exist.
  • Context-specific strategies and more data from low-resource settings are crucial for equitable global neonatal care policies.
Abstract

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
687
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
309
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
348